Sheep models of polycystic ovary syndrome phenotype

Molecular and Cellular Endocrinology

Volumn 373, Issue 1-2, 2013, Pages 8-20

  Padmanabhan, Vasantha ^a   Veiga Lopez, Almudena ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Androgens; Fetal programming; Infertility; Oestrogens; PCOS

Indexed keywords

STEROID; TESTOSTERONE;

ADULT ANIMAL; ANIMAL MODEL; BREED; DISEASE MODEL; FETUS (ANATOMY); GENETIC SUSCEPTIBILITY; GENITAL SYSTEM DISEASE; INFERTILITY; METABOLIC DISORDER; NONHUMAN; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SHEEP;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; OVARY; OVULATION; PHENOTYPE; PITUITARY GLAND; POLYCYSTIC OVARY SYNDROME; PREGNANCY; SHEEP, DOMESTIC; TESTOSTERONE;

EID: 84878106884     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.10.005     Document Type: Review

References (148)

1. Abbott D.H., Dumesic D.A., Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J. Endocrinol. 2002, 174:1-5.
2. Abbott D.H., Dumesic D.A., Levine J.E., Dunaif A., Padmanabhan V. Animal models and fetal programming of PCOS. Contemporary Endocrinology: Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and other Disorders 2006, 259-272. Humana Press Inc., Totowa, NJ. J.E. Azziz, J.E. Nestler, D. Dewailly (Eds.).
3. Anderson H., Fogel N., Grebe S.K., Singh R.J., Taylor R.L., Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J. Clin. Endocrinol. Metab. 2010, 95:2180-2186.
4. Attal J.A. Levels of testosterone, androstenedione, estrone and estradiol-17 beta in the testes of fetal sheep. Endocrinology 1969, 85:280-289.
5. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., Janssen O.E., Legro R.S., Norman R.J., Taylor A.E., Witchel S.F. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 2006, 91:4237-4245.
6. Barber T.M., McCarthy M.I., Wass J.A., Franks S. Obesity and polycystic ovary syndrome. Clin. Endocrinol. (Oxf) 2008, 65:137-145.
7. Barnes R.B., Rosenfield R.L., Ehrmann D.A., Cara J.F., Cuttler L., Levitsky L.L., Rosenthal I.M. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J. Clin. Endocrinol. Metab. 1994, 79:1328-1333.
8. Barry J.A., Kay A.R., Navaratnarajah R., Iqbal S., Bamfo J.E., David A.L., Hines M., Hardiman P.J. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J. Obstet. Gynaecol. 2010, 30:444-446.
9. Beck-Peccoz P., Padmanabhan V., Baggiani A.M., Cortelazzi D., Buscaglia M., Medri G., Marconi A.M., Pardi G., Beitins I.Z. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 1991, 73:525-532.
10. Birch R.A., Padmanabhan V., Foster D.L., Unsworth W.P., Robinson J.E. Prenatal programming of reproductive neuroendocrine function: fetal androgen exposure produces progressive disruption of reproductive cycles in sheep. Endocrinology 2003, 144:1426-1434.
11. Blank S.K., McCartney C.R., Marshall J.C. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum. Reprod. Update 2006, 12:351-361.
12. Bormann C.L., Smith G.D., Padmanabhan V., Lee T.M. Prenatal testosterone and dihydrotestosterone exposure disrupts ovine testicular development. Reproduction 2011, 142:167-173.
13. Brooks A.N., McNeilly A.S. Inhibitory effects of a luteinizing-hormone-releasing hormone agonist implant on ovine fetal gonadotrophin secretion and pituitary sensitivity to luteinizing-hormone-releasing hormone. J. Reprod. Fertil. 1992, 96:785-792.
14. Bouwens L., Lu W.G., De Krijger R. Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 1997, 40:398-404.
15. Bull L., Stubbs S., Birch R., Robinson J., Themmen A.P., Visser J.A., Groome N.P., Franks S. Reduced expression of anti-Mullerian hormone (AMH) protein in the androgenised sheep ovary. Endocrine Abstracts 2004, 8(OC13).
16. Bukovsky A., Caudle M.R., Svetlikova M., Wimalasena J., Ayala M.E., Dominguez R. Oogenesis in adult mammals, including humans: a review. Endocrine 2005, 26:301-316.
17. Caldani M., Antoine M., Batailler M., Duittoz A. Ontogeny of GnRH systems. J. Reprod. Fertil. Suppl. 1995, 49:147-162.
18. Cernea, M., Lee, T., Cheng, G., Padmanabhan, V., Lehman, M., Coolen, L. 2011. Excess prenatal testosterone increases androgen receptor expression in the female sheep brain. In: Program of the Annual Meeting of the Society for Neuroscience, Washington DC, USA, p. 499.20.
19. Cheng G., Coolen L.M., Padmanabhan V., Goodman R.L., Lehman M.N. The kisspeptin/neurokinin B/dynorphin (KNDy) cell population of the arcuate nucleus: sex differences and effects of prenatal testosterone in sheep. Endocrinology 2010, 151:301-311.
20. Clarke I.J., Scaramuzzi R.J., Short R.V. Effects of testosterone implants in pregnant ewes on their female offspring. J. Embryol. Exp. Morphol. 1976, 36:87-99.
21. Clarke I.J., Scaramuzzi R.J., Short R.V. Sexual differentiation of the brain: endocrine and behavioural responses of androgenized ewes to oestrogen. J. Endocrinol. 1976, 71:175-176.
22. Clarke I.J., Scaramuzzi R.J., Short R.V. Ovulation in prenatally androgenized ewes. J. Endocrinol. 1977, 73:385-389.
23. Clarke I.J., Scaramuzzi R.J. Release of luteinizing hormone in androgenized ewes after prostaglandin-induced luteolysis or luteinizing hormone releasing hormone. J. Endocrinol. 1978, 77:261-262.
24. Corbould A., Kim Y.B., Youngren J.F., Pender C., Kahn B.B., Lee A., Dunaif A. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E1047-1054.
25. Corbould A., Dunaif A. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism 2007, 56:716-722.
26. Corton M., Botella-Carretero J.I., Benguria A., Villuendas G., Zaballos A., San Millan J.L., Escobar-Morreale H.F., Peral B. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007, 92:328-337.
27. Davies M.J., Norman R.J. Programming and reproductive functioning. Trends. Endocrinol. Metab. 2002, 13:386-392.
28. Delic D., Grosser C., Dkhil M., Al-Quraishy S., Wunderlich F. Testosterone-induced upregulation of miRNAs in the female mouse liver. Steroids 2010, 75:998-1004.
29. Diamanti-Kandarakis E., Kandarakis H., Legro R.S. The role of genes and environment in the etiology of PCOS. Endocrine 2006, 30:19-26.
30. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 2009, 30:293-342.
31. Dolfing J.G., Stassen C.M., van Haard P.M., Wolffenbuttel B.H., Schweitzer D.H. Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS. Hum. Reprod. 2011, 26:1495-1500.
32. Driscoll S.G., Benirschke K., Curtis G.W. Neonatal deaths among infants of diabetic mothers: postmortem findings in ninety-five infants. Am. J. Dis. Child. 1960, 100:818-835.
33. Dumesic D.A., Abbott D.H., Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev. Endocr. Metab. Disord. 2007, 8:127-141.
34. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 1997, 18:774-800.
35. Dunaif A., Wu X., Lee A., Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am. J. Physiol. Endocrinol. Metab. 2001, 281:E392-399.
36. Ehrmann D.A. β-cell dysfunction, glucose intolerance, and diabetes in the polycystic syndrome. Androgen Excess Disorders in Women 2007, 319-324. Humana Press Inc., Totowa, NJ. R. Azziz, J.E. Nestler, D. Dewailly (Eds.).
37. Ewens K.G., Stewart D.R., Ankener W., Urbanek M., McAllister J.M., Chen C., Baig K.M., Parker S.C., Margulies E.H., Legro R.S., Dunaif A., Strauss J.F., Spielman R.S. Family-based analysis of candidate genes for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2010, 95:2306-2315.
38. Forsdike R.A., Hardy K., Bull L., Stark J., Webber L.J., Stubbs S., Robinson J.E., Franks S. Disordered follicle development in ovaries of prenatally androgenized ewes. J. Endocrinol. 2007, 192:421-428.
39. Fowden A.L. Pancreatic endocrine function and carbohydrate metabolism in the fetus. Research in Perinatal Medicine IV 1985, 71-90. Perinatology Press, Ithaca, NY. E. Abrecht, G.J. Pepe (Eds.).
40. Fowden A.L., Hill D.J. Intra-uterine programming of the endocrine pancreas. Br. Med. Bull. 2001, 60:123-142.
41. Fowler P.A., Bhattacharya S., Flannigan S., Drake A.J., O'Shaughnessy P.J. Maternal cigarette smoking and effects on androgen action in male offspring: unexpected effects on second-trimester anogenital distance. J. Clin. Endocrin. Metab. 2011, 3:5. (First published ahead of print July 13, 2011 as). 10.1210/jc.2011-1100.
42. Francavilla S., Cordeschi G., Properzi G., Concordia N., Cappa F., Pozzi V. Ultrastructure of fetal human gonad before sexual differentiation and during early testicular and ovarian development. J. Submicrosc. Cytol. Pathol. 1990, 22:389-400.
43. Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 1995, 333:853-861.
44. Franks S., Roberts R., Hardy K. Gonadotrophin regimens and oocyte quality in women with polycystic ovaries. Reprod. Biomed. Online 2003, 6:181-184.
45. Gemzell-Danielsson K., Marions L. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. Hum. Reprod. Update 2004, 10:341-348.
46. Glintborg D., Hojlund K., Andersen N.R., Hansen B.F., Beck-Nielsen H., Wojtaszewski J.F. Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. J. Clin. Endocrinol. Metab. 2008, 93:3618-3626.
47. Handa R.J., Pak T.R., Kudwa A.E., Lund T.D., Hinds L. An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. Horm. Behav. 2008, 53:741-752.
48. Harding J.E., Bloomfield F.H. Prenatal treatment of intrauterine growth restriction: lessons from the sheep model. Pediatr. Endocrinol. Rev. 2004, 2:182-192.
49. Hartgens F., Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports. Med. 2004, 34:513-554.
50. Herbosa C.G., Wood R.I., Foster D.L. Prenatal androgens modify the reproductive response to photoperiod in the developing sheep. Biol. Reprod. 1995, 52:163-169.
51. Herbosa C.G., Foster D.L. Defeminization of the reproductive response to photoperiod occurs early in prenatal development in the sheep. Biol. Reprod. 1996, 54:420-428.
52. Hickey M., Sloboda D.M., Atkinson H.C., Doherty D.A., Franks S., Norman R.J., Newnham J.P., Hart R. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence. a prospective cohort study. J. Clin. Endocrinol. Metab. 2009, 94:3714-3720.
53. Hileman B. Environmental estrogens linked to reproductive abnormalities, cancer. Chem. Eng. News 1994, 72:19-23.
54. Hillier S.G., Tetsuka M. Role of androgens in follicle maturation and atresia. Baillieres. Clin. Obstet. Gynaecol. 1997, 11:249-260.
55. Hogg K., McNeilly A.S., Duncan W.C. Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology 2011, 152:2048-2059.
56. Hoffman L.K., Ehrmann D.A. Cardiometabolic features of polycystic ovary syndrome. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:215-222.
57. Hojlund K., Glintborg D., Andersen N.R., Birk J.B., Treebak J.T., Frosig C., Beck-Nielsen H., Wojtaszewski J.F. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 2008, 57:357-366.
58. Holte J., Bergh T., Berne C., Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin. Endocrinol. (Oxf) 1994, 41:463-471.
59. Homburg R. Polycystic ovary syndrome: induction of ovulation. Baillieres Clin. Endocrinol. Metab. 1996, 10:281-292.
60. Jackson L.M., Timmer K.M., Foster D.L. Sexual differentiation of the external genitalia and the timing of puberty in the presence of an antiandrogen in sheep. Endocrinology 2008, 149:4200-4208.
61. Jin J.L., Sun J., Ge H.J., Cao Y.X., Wu X.K., Liang F.J., Sun H.X., Ke L., Yi L., Wu Z.W., Wang Y. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women. BMC. Med. Genet. 2009, 10:139.
62. Kallen B., Mastroiacovo P., Lancaster P.A., Mutchinick O., Kringelbach M., Martinez-Frias M.L., Robert E., Castilla E.E. Oral contraceptives in the etiology of isolated hypospadias. Contraception 1991, 44:173-182.
63. Kaplan S.L., Grumbach M.M., Aubert M.L. The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system regulation of anterior pituitary function. Recent. Prog. Horm. Res. 1976, 32:161-243.
64. Kandaraki E., Chatzigeorgiou A., Livadas S., Palioura E., Economou F., Koutsilieris M., Palimeri S., Panidis D., Diamanti-Kandarakis E. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J. Clin. Endocrinol. Metab. 2011, 96:E480-484.
65. Kasa-Vubu J.Z., Dahl G.E., Evans N.P., Thrun L.A., Moenter S.M., Padmanabhan V., Karsch F.J. Progesterone blocks the estradiol-induced gonadotropin discharge in the ewe by inhibiting the surge of gonadotropin-releasing hormone. Endocrinology 1992, 131:208-212.
66. King A.J., Olivier N.B., Mohankumar P.S., Lee J.S., Padmanabhan V., Fink G.D. Hypertension caused by prenatal testosterone excess in female sheep. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1837-1841.
67. Kosut S.S., Wood R.I., Herbosa-Encarnacion C., Foster D.L. Prenatal androgens time neuroendocrine puberty in the sheep: effect of testosterone dose. Endocrinology 1997, 138:1072-1077.
68. Ledoux S., Campos D.B., Lopes F.L., Dobias-Goff M., Palin M.F., Murphy B.D. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 2006, 147:5178-5186.
69. Levine J.E. New concepts of the neuroendocrine regulation of gonadotropin surges in rats. Biol. Reprod. 1997, 56:293-302.
70. Li D.K., Daling J.R., Mueller B.A., Hickok D.E., Fantel A.G., Weiss N.S. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Teratology 1995, 51:30-36.
71. Luense, L.J., Christenson, L.K., Padmanabhan, V., 2010a. Developmental programming: Gestational testosterone treatment alters fetal ovarian steroidogenic gene expression. In: 43rd Annual Meeting of the Society for Study of Reproduction, Milwaukee, Wisconsin, Biol. Reprod. vol. 83(Suppl.), p. 183.
72. Luense, L.J., Padmanabhan, V., Christenson, L.K. 2010b. Developmental Programming: Maternal testosterone excess fetal ovarian mRNA and microRNA gene expression. In: 17th Ovarian Workshop, vol. 44. Milwaukee, MD. p. 44.
73. Mai K., Bobbert T., Reinecke F., Andres J., Maser-Gluth C., Wudy S.A., Mohlig M., Weickert M.O., Hartmann M.F., Schulte H.M., Diederich S., Pfeiffer A.F., Spranger J. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. J. Clin. Endocrinol. Metab. 2008, 93:3900-3906.
74. Makabe S., Naguro T., Stallone T. Oocyte-follicle cell interactions during ovarian follicle development, as seen by high resolution scanning and transmission electron microscopy in humans. Microsc. Res. Tech. 2006, 69:436-449.
75. Manikkam M., Crespi E.J., Doop D.D., Herkimer C., Lee J.S., Yu S., Brown M.B., Foster D.L., Padmanabhan V. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004, 145:790-798.
76. Manikkam M., Steckler T.L., Welch K.B., Inskeep E.K., Padmanabhan V. Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology 2006, 147:1997-2007.
77. Manikkam M., Thompson R.C., Herkimer C., Welch K.B., Flak J., Karsch F.J., Padmanabhan V. Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biol. Reprod. 2008, 78:648-660.
78. Martínez-Bermejo E., Luque-Ramírez M., Escobar-Morreale H.F. Obesity and the polycystic ovary syndrome. Minerva Endocrinol. 2007, 32:129-140.
79. Masek K.S., Wood R.I., Foster D.L. Prenatal dihydrotestosterone differentially masculinizes tonic and surge modes of luteinizing hormone secretion in sheep. Endocrinology 1999, 140:3459-3466.
80. Matwijiw I., Thliveris J.A., Faiman C. Hypothalamo-pituitary portal development in the ovine fetus. Biol. Reprod. 1989, 40:1127-1130.
81. McCartney C.R., Eagleson C.A., Marshall J.C. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin. Reprod. Med. 2002, 20:317-326.
82. McGee E.A., Hsueh A.J. Initial and cyclic recruitment of ovarian follicles. Endocr. Rev. 2000, 21:200-214.
83. McNatty K.P., Fidler A.E., Juengel J.L., Quirke L.D., Smith P.R., Heath D.A., Lundy T., O'Connell A., Tisdall D.J. Growth and paracrine factors regulating follicular formation and cellular function. Mol. Cell. Endocrinol. 2000, 163:11-20.
84. Nada S., Thompson R.C., Padmanabhan V. Developmental programming: prenatal testosterone excess has differential effects on the developmental trajectory of members of the insulin signaling cascade in liver and skeletal muscle. Biol. Reprod. 2009, 81(Suppl):342.
85. Nada S.E., Thompson R.C., Padmanabhan V. Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues. Endocrinology 2010, 151:5165-5173.
86. Narayanan R., Jiang J., Gusev Y., Jones A., Kearbey J.D., Miller D.D., Schmittgen T.D., Dalton J.T. MicroRNAs are mediators of androgen action in prostate and muscle. PLoS One 2010, 5:e13637.
87. Ortega H.H., Salvetti N.R., Padmanabhan V. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction 2009, 137:865-877.
88. Ortega H.H., Rey F., Velazquez M.M., Padmanabhan V. Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol. Reprod. 2010, 82:1065-1075.
89. Ortega, H., Salvetti, N., Veiga-Lopez, A., Padmanabhan, V., Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and survival factors. In: 44th Annual Meeting of the Society for the Study of Reproduction. Portland, Oregon (USA), 31 July-4 August, 2011.
90. Padmanabhan, V., Veiga-Lopez, A., Abbott, D.H., Dumesic, D.A., 2007. Developmental programming of ovarian dysfunction. In: Gonzalez-Bulnes, A., (Eds.), Novel concepts in ovarian endocrinology. Research Signpost Editors, Kerala, India, pp. 329-352.
91. Padmanabhan V., Sarma H.N., Savabieasfahani M., Steckler T.L., Veiga-Lopez A. Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators. Int. J. Androl. 2010, 33:394-404.
92. Padmanabhan V., Veiga-Lopez A., Abbott D.H., Recabarren S.E., Herkimer C. Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 2010, 151:595-605.
93. Padmanabhan V., Veiga-Lopez A. Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin. Reprod. Med. 2011, 29:173-186.
94. Padmanabhan, V., Patel, D., Veiga-Lopez, A., Pease, A., Kinns, J., 2011. Developmental Programming: adipose tissue distribution in prenatal testosterone-treated sheep. In: 93rd Annual Meeting of the Endocrine Society. Boston, USA. p. 443.
95. Polkowska J., Dubois M.P., Jutisz M. Maturation of luteinizing hormone-releasing hormone (LHRH) and somatostatin (SRIF) neuronal systems in the hypothalamus of growing ewe lambs. Reprod. Nutr. Dev. 1987, 27:627-639.
96. Pomerantz D.K., Nalbandov A.V. Androgen level in the sheep fetus during gestation. Proc. Soc. Exp. Biol. Med. 1975, 149:413-416.
97. Prodoehl M.J., Hatzirodos N., Irving-Rodgers H.F., Zhao Z.Z., Painter J.N., Hickey T.E., Gibson M.A., Rainey W.E., Carr B.R., Mason H.D., Norman R.J., Montgomery G.W., Rodgers R.J. Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol. Hum. Reprod. 2009, 15:829-841.
98. Rebar R., Judd H.L., Yen S.S., Rakoff J., Vandenberg G., Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 1976, 57:1320-1329.
99. Recabarren S.E., Padmanabhan V., Codner E., Lobos A., Duran C., Vidal M., Foster D.L., Sir-Petermann T. Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E801-806.
100. Recabarren S.E., Rojas-García P.P., Recabarren M.P., Alfaro V.H., Smith R., Padmanabhan V., Sir-Petermann T. Prenatal testosterone excess reduces sperm count and motility. Endocrinology 2008, 149:6444-6448.
101. Reddy S., Bibby N.J., Elliott R.B. An immunofluorescent study of insulin-, glucagon-, pancreatic polypeptide- and somatostatin-containing cells in the early ovine fetal pancreas. Q. J. Exp. Physiol. 1988, 73:225-232.
102. Rhind S.M., Rae M.T., Brooks A.N. Effects of nutrition and environmental factors on the fetal programming of the reproductive axis. Reproduction 2001, 122:205-214.
103. Robinson J.E., Forsdike R.A., Taylor J.A. In utero exposure of female lambs to testosterone reduces the sensitivity of the gonadotropin-releasing hormone neuronal network to inhibition by progesterone. Endocrinology 1999, 140:5797-5805.
104. Rojas-García P.P., Recabarren M.P., Sarabia L., Schön J., Gabler C., Einspanier R., Maliqueo M., Sir-Petermann T., Rey R., Recabarren S.E. Prenatal testosterone excess alters Sertoli and germ cell number and testicular FSH receptor expression in rams. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E998-E1005.
105. Rosenfield R.L. Current concepts of polycystic ovary syndrome. Baillieres. Clin. Obstet. Gynaecol. 1997, 11:307-333.
106. Rouiller-Fabre V., Lambrot R., Muczynski V., Coffigny H., Lecureuil C., Pairault C., Bakalska M., Courtot A.M., Frydman R., Habert R. Development and regulations of testicular functions in the human foetus. Gynecol. Obstet. Fertil. 2008, 36:898-907.
107. Sam S., Coviello A.D., Sung Y.A., Legro R.S., Dunaif A. Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care 2008, 31:1237-1241.
108. Sarma H.N., Manikkam M., Herkimer C., Dell'Orco J., Welch K.B., Foster D.L., Padmanabhan V. Fetal programming: excess prenatal testosterone reduces postnatal luteinizing hormone, but not follicle-stimulating hormone responsiveness, to estradiol negative feedback in the female. Endocrinology 2005, 146:4281-4291.
109. Savabieasfahani M., Lee J.S., Herkimer C., Sharma T.P., Foster D.L., Padmanabhan V. Fetal programming: testosterone exposure of the female sheep during midgestation disrupts the dynamics of its adult gonadotropin secretion during the periovulatory period. Biol. Reprod. 2005, 72:221-229.
110. Sawyer H.R., Smith P., Heath D.A., Juengel J.L., Wakefield S.J., McNatty K.P. Formation of ovarian follicles during fetal development in sheep. Biol. Reprod. 2002, 66:1134-1150.
111. Schwanzel-Fukuda M. Origin and migration of luteinizing hormone-releasing hormone neurons in mammals. Microsc. Res. Tech. 1999, 44:2-10.
112. Seminara S.B., Hayes F.J., Crowley W.F. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr. Rev. 1998, 19:521-539.
113. Seow K.M., Juan C.C., Hsu Y.P., Hwang J.L., Huang L.W., Ho L.T. Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum. Reprod. 2007, 22:1003-1010.
114. Sharma T.P., Herkimer C., West C., Ye W., Birch R., Robinson J.E., Foster D.L., Padmanabhan V. Fetal programming: prenatal androgen disrupts positive feedback actions of estradiol but does not affect timing of puberty in female sheep. Biol. Reprod. 2002, 66:924-933.
115. Sheppard K.M., Padmanabhan V., Coolen L.M., Lehman M.N. Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe. J. Neuroendocrinol. 2011, 23:401-411.
116. Short R.V. Sexual differentiation of the sheep brain. Sexual Endocrinol. Perinatal. Period. 1974, 73:121-142.
117. Smith P., Steckler T.L., Veiga-Lopez A., Padmanabhan V. Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol. Reprod. 2009, 80:726-736.
118. Steckler T., Wang J., Bartol F.F., Roy S.K., Padmanabhan V. Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology 2005, 146:3185-3193.
119. Steckler T., Manikkam M., Inskeep E.K., Padmanabhan V. Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology 2007, 148:3532-3540.
120. Steckler T.L., Roberts E.K., Doop D.D., Lee T.M., Padmanabhan V. Developmental programming in sheep: administration of testosterone during 60-90days of pregnancy reduces breeding success and pregnancy outcome. Theriogenology 2007, 67:459-467.
121. Steckler T.L., Lee J.S., Ye W., Inskeep E.K., Padmanabhan V. Developmental programming: exogenous gonadotropin treatment rescues ovulatory function but does not completely normalize ovarian function in sheep treated prenatally with testosterone. Biol. Reprod. 2008, 79:686-695.
122. Steckler T.L., Herkimer C., Dumesic D.A., Padmanabhan V. Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication for polycystic ovary syndrome. Endocrinology 2009, 150:1456-1465.
123. Stein I.F., Leventhal M.L. Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 1935, 29:181-191.
124. Takeuchi T., Tsutsumi O., Ikezuki Y., Takai Y., Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr. J. 2004, 51:165-169.
125. Takeuchi T., Tsutsumi O., Ikezuki Y., Kamei Y., Osuga Y., Fujiwara T., Takai Y., Momoeda M., Yano T., Taketani Y. Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity. Endocr. J. 2006, 53:485-491.
126. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). 2004. Hum. Reprod. 19, 41-47.
127. Unsworth W.P., Taylor J.A., Robinson J.E. Prenatal programming of reproductive neuroendocrine function: the effect of prenatal androgens on the development of estrogen positive feedback and ovarian cycles in the ewe. Biol. Reprod. 2005, 72:619-627.
128. Urbanek M., Woodroffe A., Ewens K.G., Diamanti-Kandarakis E., Legro R.S., Strauss J.F., Dunaif A., Spielman R.S. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J. Clin. Endocrinol. Metab. 2005, 90:6623-6629.
129. Veiga-Lopez A., Ye W., Phillips D.J., Herkimer C., Knight P.G., Padmanabhan V. Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep. Biol. Reprod. 2008, 78:636-647.
130. Veiga-Lopez A., Astapova O.I., Aizenberg E.F., Lee J.S., Padmanabhan V. Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep. Biol. Reprod. 2009, 80:718-725.
131. Veiga-Lopez A., Lee J.S., Padmanabhan V. Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep. Endocrinology 2010, 151:4007-4017.
132. Veiga-Lopez, A., Padmanabhan, V., 2010. Developmental programming: prenatal testosterone excess disrupts expression of oocyte and granulosa cell growth factors in sheep. In: 43rd Annual Meeting of the Society for the Study of Reproduction, vol. 83(Suppl). Milwaukee, Wisconsin, USA. Biol. Reprod. p. 79.
133. Veiga-Lopez, A., Burant, C., Padmanabhan, V., 2011a. Developmental Programming: prenatal testosterone and postnatal obesity induce free fatty acid imbalance in sheep. In: 93rd Annual Meeting of the Endocrine Society, Boston, USA, p. 55.
134. Veiga-Lopez A., Steckler T.L., Abbott D.H., Welch K.B., MohanKumar P.S., Phillips D.J., Refsal K., Padmanabhan V. Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol. Reprod. 2011, 84:87-96.
135. Vendola K.A., Zhou J., Adesanya O.O., Weil S.J., Bondy C.A. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest. 1998, 101:2622-2629.
136. Vink J.M., Sadrzadeh S., Lambalk C.B., Boomsma D.I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 2006, 91:2100-2104.
137. Walters K.A., Allan C.M., Handelsman D.J. Androgen actions and the ovary. Biol. Reprod. 2008, 78:380-389.
138. Webber L.J., Stubbs S., Stark J., Trew G.H., Margara R., Hardy K., Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003, 362:1017-1021.
139. West C., Foster D.L., Evans N.P., Robinson J., Padmanabhan V. Intra-follicular activin availability is altered in prenatally-androgenized lambs. Mol. Cell. Endocrinol. 2001, 185:51-59.
140. Wild R.A., Carmina E., Diamanti-Kandarakis E., Dokras A., Escobar-Morreale H.F., Futterweit W., Lobo R., Norman R.J., Talbott E., Dumesic D.A. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 2010, 95:2038-2049.
141. Wilson P.R., Tarttelin M.F. Studies on sexual differentiation of sheep. I. Foetal and maternal modifications and post-natal plasma LH and testosterone content following androgenisation early in gestation. Acta. Endocrinol. (Copenh) 1978, 89:182-189.
142. Wilson P.R., Tarttelin M.F. Studies of sexual differentiation of sheep. II. Evidence for post-natal hypothalamic hypophysiotrophic depression of basal LH secretion following pre-natal androgenisation. Acta. Endocrinol. (Copenh) 1978, 89:190-195.
143. Wood R.I., Ebling F.J., I'Anson H., Bucholtz D.C., Yellon S.M., Foster D.L. Prenatal androgens time neuroendocrine sexual maturation. Endocrinology 1991, 128:2457-2468.
144. Wood R.I., Mehta V., Herbosa C.G., Foster D.L. Prenatal testosterone differentially masculinizes tonic and surge modes of luteinizing hormone secretion in the developing sheep. Neuroendocrinology 1995, 62:238-247.
145. Wood R.I., Foster D.L. Sexual differentiation of reproductive neuroendocrine function in sheep. Rev. Reprod. 1998, 3:130-140.
146. Yildiz B.O., Yarali H., Oguz H., Bayraktar M. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003, 88:2031-2036.
147. Yildiz B.O., Azziz R. The adrenal and polycystic ovary syndrome. Rev. Endocr. Metab. Disord. 2007, 8:331-342.
148. Zawadki J.K., Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic Ovary Syndrome 1992, 377-384. Blackwell Scientific Publications, Boston. A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam (Eds.).